141 related articles for article (PubMed ID: 8938475)
1. Serial color Doppler flow of uterine vasculature combined with serum beta-hCG measurements for improved monitoring of patients with gestational trophoblastic disease. A preliminary report.
Maymon R; Schneider D; Shulman A; Bukowsky I; Weinraub Z
Gynecol Obstet Invest; 1996; 42(3):201-5. PubMed ID: 8938475
[TBL] [Abstract][Full Text] [Related]
2. The role of color Doppler flow in the management of nonmetastatic gestational trophoblastic disease.
Tepper R; Shulman A; Altaras M; Goldberger S; Maymon R; Holzinger M; Beyth Y
Gynecol Obstet Invest; 1994; 38(1):14-7. PubMed ID: 7959318
[TBL] [Abstract][Full Text] [Related]
3. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
4. Vascular patterns of gestational trophoblastic tumors by color Doppler ultrasound.
Hsieh FJ; Wu CC; Lee CN; Chen TM; Chen CA; Chen FC; Chen CL; Hsieh CY
Cancer; 1994 Oct; 74(8):2361-5. PubMed ID: 7522951
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound imaging after evacuation as an adjunct to beta-hCG monitoring in posthydatidiform molar gestational trophoblastic neoplasia.
Garavaglia E; Gentile C; Cavoretto P; Spagnolo D; Valsecchi L; Mangili G
Am J Obstet Gynecol; 2009 Apr; 200(4):417.e1-5. PubMed ID: 19200936
[TBL] [Abstract][Full Text] [Related]
6. Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study.
Asmar FTC; Braga-Neto AR; de Rezende-Filho J; Villas-Boas JMS; Charry RC; Maesta I
Clinics (Sao Paulo); 2017 May; 72(5):284-288. PubMed ID: 28591340
[TBL] [Abstract][Full Text] [Related]
7. Serial hCG and ultrasound measurements for predicting malignant potential in multiple pregnancies associated with complete hydatidiform mole: a report of 2 cases.
Steigrad SJ; Robertson G; Kaye AL
J Reprod Med; 2004 Jul; 49(7):554-8. PubMed ID: 15305827
[TBL] [Abstract][Full Text] [Related]
8. Radiology rounds. Molar pregnancy (hydatidiform mole; gestational trophoblastic disease).
McLennan MK
Can Fam Physician; 1999 Jan; 45():49, 61-2. PubMed ID: 10889855
[No Abstract] [Full Text] [Related]
9. Nonmetastatic gestational trophoblastic neoplasia. Role of ultrasonography and magnetic resonance imaging.
Kohorn EI; McCarthy SM; Taylor KJ
J Reprod Med; 1998 Jan; 43(1):14-20. PubMed ID: 9475144
[TBL] [Abstract][Full Text] [Related]
10. Uterine artery Doppler blood flow in cases of hydatidiform mole and its correlation with beta-hCG.
Abd El Aal DE; El Senosy ED; Kamel MA; Atwa M
Eur J Obstet Gynecol Reprod Biol; 2003 Dec; 111(2):129-34. PubMed ID: 14597239
[TBL] [Abstract][Full Text] [Related]
11. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
12. The utilization of Doppler ultrasonography with color flow mapping in the diagnosis and evaluation of malignant trophoblastic tumors.
Park YW; Kim DK; Cho JS; Kim HS; Park YJ; Kim JW; Park TK
Yonsei Med J; 1994 Sep; 35(3):329-35. PubMed ID: 7975742
[TBL] [Abstract][Full Text] [Related]
13. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
Fan C; Goto S; Furuhashi Y; Tomoda Y
J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of F-18 fluorodeoxyglucose positron emission tomography and computed tomography in molar pregnancy before evacuation.
Ak I; Ozalp S
J Reprod Med; 2009 Jul; 54(7):441-6. PubMed ID: 19691261
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
Duc HN; van Trommel NE; Sweep FC; Massuger LF; Thomas CM
Int J Biol Markers; 2006; 21(1):45-9. PubMed ID: 16711513
[TBL] [Abstract][Full Text] [Related]
20. Is normal beta-hCG regression curve helpful in the diagnosis of persistent trophoblastic disease?
Behtash N; Ghaemmaghami F; Honar H; Riazi K; Nori A; Modares M; Mousavi A
Int J Gynecol Cancer; 2004; 14(5):980-3. PubMed ID: 15361212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
